与心脏重同步治疗中的双心室节奏相比,使用左捆支部区域节奏改善了全因死亡率:一个元分析
Juan Carlos Diaz1, Mohamed Gabr2, Usha B Tedrow2
1Cardiac Arrhythmia and Electrophysiology Service, Division of Cardiology, Clinica Las Vegas, Universidad CES Medical School, Medellin, Colombia.
概括
与心脏再同步治疗中的双心室节律 (BIVP) 相比,左捆支部区域节奏 (LBBAP) 显著降低了死亡率和心力衰竭住院病例. 此外,LBBAP还可以提高程序效率和心声回声测量.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 左捆支部区域节奏 (LBBAP) 是心脏再同步治疗 (CRT) 的一种新节奏策略.
- 它提供了一个生理学上的替代传统的双心脏节奏 (BIVP).
研究的目的:
- 在CRT患者中比较LBBAP与BIVP的疗效.
- 评估对所有原因死亡率和心力衰竭 (HF) 相关住院治疗的影响.
主要方法:
- 一项对13项研究 (3239名患者) 的元分析,比较LBBAP和BIVP用于CRT.
- 首要结局包括全因死亡率和与HF相关的住院治疗.
- 二次结果:手术/光学时间,QRS持续时间和LVEF变化.
主要成果:
- 与BIVP相比,LBBAP显示所有原因死亡率显著降低 (3.2%的绝对风险降低).
- 此外,LBBAP还显著减少了与高频率相关的住院病例 (绝对风险降低8.2%).
- 与BIVP相比,LBBAP减少了手术/光学时间,QRS持续时间,并改善了LVEF.
结论:
- 与BIVP相比,LBBAP与所有原因死亡率和HF住院率显著降低.
- 在程序效率和心脏功能改善方面,LBBAP提供了好处.
- 建议进一步进行大型随机对照试验,以证实这些发现.
相关概念视频
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


